These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

371 related items for PubMed ID: 31885725

  • 21. Acupuncture prevents 6-hydroxydopamine-induced neuronal death in the nigrostriatal dopaminergic system in the rat Parkinson's disease model.
    Park HJ, Lim S, Joo WS, Yin CS, Lee HS, Lee HJ, Seo JC, Leem K, Son YS, Kim YJ, Kim CJ, Kim YS, Chung JH.
    Exp Neurol; 2003 Mar; 180(1):93-8. PubMed ID: 12668152
    [Abstract] [Full Text] [Related]

  • 22. Involvement of adenosine triphosphate-sensitive potassium channels in the neuroprotective activity of hydrogen sulfide in the 6-hydroxydopamine-induced animal model of Parkinson's disease.
    Sarookhani MR, Haghdoost-Yazdi H, Sarbazi-Golezari A, Babayan-Tazehkand A, Rastgoo N.
    Behav Pharmacol; 2018 Jun; 29(4):336-343. PubMed ID: 29239973
    [Abstract] [Full Text] [Related]

  • 23. Neuroprotective effect of hydroxysafflor yellow A on 6-hydroxydopamine-induced Parkinson's disease in rats.
    Han B, Hu J, Shen J, Gao Y, Lu Y, Wang T.
    Eur J Pharmacol; 2013 Aug 15; 714(1-3):83-8. PubMed ID: 23791614
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Protective and therapeutic activity of honokiol in reversing motor deficits and neuronal degeneration in the mouse model of Parkinson's disease.
    Chen HH, Chang PC, Chen C, Chan MH.
    Pharmacol Rep; 2018 Aug 15; 70(4):668-676. PubMed ID: 29909247
    [Abstract] [Full Text] [Related]

  • 28. Engrafted primary type-2 astrocytes improve the recovery of the nigrostriatal pathway in a rat model of Parkinson's disease.
    Sun Y, Lu XJ, Fu X, Zhang Y, Zhan Y, Liu J, Zhao L, Xia CL.
    Mol Cell Biochem; 2021 Feb 15; 476(2):619-631. PubMed ID: 33070275
    [Abstract] [Full Text] [Related]

  • 29. The anti-aging protein klotho alleviates injury of nigrostriatal dopaminergic pathway in 6-hydroxydopamine rat model of Parkinson's disease: Involvement of PKA/CaMKII/CREB signaling.
    Baluchnejadmojarad T, Eftekhari SM, Jamali-Raeufy N, Haghani S, Zeinali H, Roghani M.
    Exp Gerontol; 2017 Dec 15; 100():70-76. PubMed ID: 29107062
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Delayed gene therapy of glial cell line-derived neurotrophic factor is efficacious in a rat model of Parkinson's disease.
    Zheng JS, Tang LL, Zheng SS, Zhan RY, Zhou YQ, Goudreau J, Kaufman D, Chen AF.
    Brain Res Mol Brain Res; 2005 Mar 24; 134(1):155-61. PubMed ID: 15790539
    [Abstract] [Full Text] [Related]

  • 33. Peripheral administration of the Class-IIa HDAC inhibitor MC1568 partially protects against nigrostriatal neurodegeneration in the striatal 6-OHDA rat model of Parkinson's disease.
    Mazzocchi M, Goulding SR, Morales-Prieto N, Foley T, Collins LM, Sullivan AM, O'Keeffe GW.
    Brain Behav Immun; 2022 May 24; 102():151-160. PubMed ID: 35217173
    [Abstract] [Full Text] [Related]

  • 34. Acetyl-l-carnitine protects dopaminergic nigrostriatal pathway in 6-hydroxydopamine-induced model of Parkinson's disease in the rat.
    Afshin-Majd S, Bashiri K, Kiasalari Z, Baluchnejadmojarad T, Sedaghat R, Roghani M.
    Biomed Pharmacother; 2017 May 24; 89():1-9. PubMed ID: 28199883
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Lesion of the subthalamic nucleus reverses motor deficits but not death of nigrostriatal dopaminergic neurons in a rat 6-hydroxydopamine-lesion model of Parkinson's disease.
    Rizelio V, Szawka RE, Xavier LL, Achaval M, Rigon P, Saur L, Matheussi F, Delattre AM, Anselmo-Franci JA, Meneses M, Ferraz AC.
    Braz J Med Biol Res; 2010 Jan 24; 43(1):85-95. PubMed ID: 19967265
    [Abstract] [Full Text] [Related]

  • 40. STAT3 protects dopaminergic neurons against degeneration in animal model of Parkinson's disease.
    Smit RD, Ghosh B, Campion TJ, Stingel R, Lavell E, Hooper R, Fan X, Soboloff J, Smith GM.
    Brain Res; 2024 Feb 01; 1824():148691. PubMed ID: 38030102
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.